FI98829B - Förfarande för framställning av rekombinerat proteinkomplex med humanfaktor VIII:C aktivitet - Google Patents

Förfarande för framställning av rekombinerat proteinkomplex med humanfaktor VIII:C aktivitet

Info

Publication number
FI98829B
FI98829B FI870261A FI870261A FI98829B FI 98829 B FI98829 B FI 98829B FI 870261 A FI870261 A FI 870261A FI 870261 A FI870261 A FI 870261A FI 98829 B FI98829 B FI 98829B
Authority
FI
Finland
Prior art keywords
factor viii
activity
protein complex
preparation
recombinant protein
Prior art date
Application number
FI870261A
Other languages
English (en)
Finnish (fi)
Other versions
FI870261A0 (sv
FI870261A (sv
FI98829C (sv
Inventor
Rae Lyn Burke
Mirella Ezban Rasmussen
Original Assignee
Chiron Corp
Nordisk Gentofte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp, Nordisk Gentofte filed Critical Chiron Corp
Publication of FI870261A0 publication Critical patent/FI870261A0/sv
Publication of FI870261A publication Critical patent/FI870261A/sv
Application granted granted Critical
Publication of FI98829B publication Critical patent/FI98829B/sv
Publication of FI98829C publication Critical patent/FI98829C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
FI870261A 1986-01-27 1987-01-21 Förfarande för framställning av rekombinerat proteinkomplex med humanfaktor VIII:C aktivitet FI98829C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82298986A 1986-01-27 1986-01-27
US82298986 1986-01-27

Publications (4)

Publication Number Publication Date
FI870261A0 FI870261A0 (sv) 1987-01-21
FI870261A FI870261A (sv) 1987-07-28
FI98829B true FI98829B (sv) 1997-05-15
FI98829C FI98829C (sv) 1997-08-25

Family

ID=25237495

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870261A FI98829C (sv) 1986-01-27 1987-01-21 Förfarande för framställning av rekombinerat proteinkomplex med humanfaktor VIII:C aktivitet

Country Status (9)

Country Link
EP (1) EP0232112B1 (sv)
JP (3) JPH0797996B2 (sv)
AT (1) ATE97956T1 (sv)
AU (1) AU610059B2 (sv)
DE (1) DE3788289T2 (sv)
DK (1) DK175407B1 (sv)
ES (1) ES2059361T3 (sv)
FI (1) FI98829C (sv)
NO (1) NO179106C (sv)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138505B1 (en) 1984-01-12 2006-11-21 Novartis Vaccines And Diagnostics, Inc. Factor VIII:C nucleic acid molecules
KR910006424B1 (ko) * 1985-08-21 1991-08-24 인코텍스 비.브이 편성브리프(brief) 제조방법
US5198349A (en) * 1986-01-03 1993-03-30 Genetics Institute, Inc. Method for producing factor VIII:C and analogs
US5595886A (en) 1986-01-27 1997-01-21 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
US5422260A (en) * 1986-05-29 1995-06-06 Genetics Institute, Inc. -Legal Affairs Human factor VIII:c muteins
EP0251843A1 (fr) * 1986-06-06 1988-01-07 Transgene S.A. Procédé de préparation de facteur VIII à partir de cellules de mammifères
FR2613379B2 (fr) * 1987-04-03 1990-04-06 Transgene Sa Procede de preparation de fragments du facteur viii a partir de cellules de mammiferes
IL83192A (en) * 1986-07-18 1992-11-15 Gist Brocades Nv Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies
US6060447A (en) * 1987-05-19 2000-05-09 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
US6346513B1 (en) 1987-06-12 2002-02-12 Baxter Trading Gmbh Proteins with factor VIII activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
EP0690126B1 (en) * 1987-06-12 2001-11-28 Baxter Aktiengesellschaft Novel proteins with factor VIII activitiy: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
AU627150B2 (en) * 1987-06-12 1992-08-20 Immuno Ag Novel proteins with factor viii activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
IE69026B1 (en) * 1987-06-12 1996-08-07 Immuno Ag Novel proteins with factor VIII activity process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
JPH0387173A (ja) * 1987-09-10 1991-04-11 Teijin Ltd ヒト活性化天然型ファクター８ｃの製造方法及びそれに用いる形質転換体
WO1991007490A1 (en) * 1989-11-17 1991-05-30 Novo Nordisk A/S Protein complexes having factor viii:c activity and production thereof
FR2657884B1 (fr) 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
US5610033A (en) * 1990-04-25 1997-03-11 Novo Nordisk A/S Method of producing proteins with FVIII activity and/or FVIII derivatives
CA2078721A1 (en) * 1991-09-24 1993-03-25 Hiroshi Yonemura Process for preparing human coagulation factor viii protein complex
DK53792D0 (da) * 1992-04-24 1992-04-24 Novo Nordisk As Fremgangsmaade til fremstilling af proteiner
US6221349B1 (en) 1998-10-20 2001-04-24 Avigen, Inc. Adeno-associated vectors for expression of factor VIII by target cells
US6200560B1 (en) 1998-10-20 2001-03-13 Avigen, Inc. Adeno-associated virus vectors for expression of factor VIII by target cells
US7906111B2 (en) 2003-09-30 2011-03-15 The Trustees Of The University Of Pennsylvania Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
EP1707634A1 (en) 2005-03-29 2006-10-04 Octapharma AG Method for isolation of recombinantly produced proteins
EP1866422B1 (en) 2005-04-07 2016-04-06 The Trustees of The University of Pennsylvania Method of increasing the function of an aav vector
EP1739179A1 (en) 2005-06-30 2007-01-03 Octapharma AG Serum-free stable transfection and production of recombinant human proteins in human cell lines
WO2011095604A1 (en) 2010-02-04 2011-08-11 Octapharma Biopharmaceuticals Gmbh Half-life prolongation of proteins
US9315825B2 (en) 2010-03-29 2016-04-19 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
SG183929A1 (en) 2010-03-29 2012-10-30 Univ Pennsylvania Pharmacologically induced transgene ablation system
TR201908020T4 (tr) 2011-02-17 2019-06-21 Univ Pennsylvania Doku özgüllüğünü değiştirmek ve aav9-aracılı gen transferini geliştirmek için bileşimler ve yöntemler.
US9719106B2 (en) 2013-04-29 2017-08-01 The Trustees Of The University Of Pennsylvania Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
CN115074366A (zh) 2015-04-16 2022-09-20 埃默里大学 用于肝脏中蛋白质表达的重组启动子和载体及其用途
JP6577401B2 (ja) 2016-03-31 2019-09-18 本田技研工業株式会社 ダクトへのレゾネータの取付け構造
EP4192515A2 (en) 2020-08-07 2023-06-14 Amicus Therapeutics, Inc. Vesicle targeting proteins and uses of same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534273B1 (fr) * 1982-10-07 1985-09-13 Pasteur Institut Lignees cellulaires originaires de mammiferes superieurs, productrices d'hormone de croissance, de preference humaine, et vecteurs pour leur obtention
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4657894A (en) * 1983-03-31 1987-04-14 Scripps Clinic & Research Foundation New factor VIII coagulant polypeptides
US4840896A (en) * 1983-11-02 1989-06-20 Integrated Genetics, Inc. Heteropolymeric protein
DE10399011I1 (de) * 1984-01-12 2003-10-23 Chiron Corp F}r Fakton-VIIIc kodierende DNA-Sequenzen und ver wandte DNA-Konstruktionen
SE8501050D0 (sv) * 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
AU5772886A (en) * 1985-04-12 1986-11-05 Genetics Institute Inc. Novel procoagulant proteins
IL83192A (en) * 1986-07-18 1992-11-15 Gist Brocades Nv Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies

Also Published As

Publication number Publication date
JPH07278197A (ja) 1995-10-24
FI870261A0 (sv) 1987-01-21
DE3788289D1 (de) 1994-01-13
FI870261A (sv) 1987-07-28
EP0232112A3 (en) 1987-12-23
DK42887A (da) 1987-07-28
FI98829C (sv) 1997-08-25
JPS62282594A (ja) 1987-12-08
DK42887D0 (da) 1987-01-27
JPH0771496B2 (ja) 1995-08-02
JP2513993B2 (ja) 1996-07-10
NO179106B (no) 1996-04-29
ES2059361T3 (es) 1994-11-16
NO870323L (no) 1987-07-28
ATE97956T1 (de) 1993-12-15
DE3788289T2 (de) 1994-06-23
EP0232112B1 (en) 1993-12-01
JPH06205678A (ja) 1994-07-26
AU6801487A (en) 1987-07-30
DK175407B1 (da) 2004-09-27
NO179106C (no) 1996-08-07
AU610059B2 (en) 1991-05-16
NO870323D0 (no) 1987-01-27
JPH0797996B2 (ja) 1995-10-25
EP0232112A2 (en) 1987-08-12

Similar Documents

Publication Publication Date Title
FI98829B (sv) Förfarande för framställning av rekombinerat proteinkomplex med humanfaktor VIII:C aktivitet
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
NO874495L (no) Ekspresjon av protein c.
NO308310B1 (no) Hovedsakelig rent KGF protein og dets anvendelse
PT85349A (en) Method for the preparation of proteins with factor viii activity by microbial host cells expression vectors host cells antibodies
DE69833784D1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
NO862601D0 (no) Ekspresjon av protein c.
IL88151A (en) Interleukin-7 protein, dna sequences encoding it, its preparation and compositions containing it
DE60043428D1 (de) POLYPEPTIDE MIT VERZWEIGUNGSENZYM-AKTIVITäT UND FüR DIESE KODIERENDE NUKLEINSäUREN
DE3751632D1 (de) Expression von biologisch-aktiven PDGF-Analogen in eukaryotischen Zellen
DE69837475D1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
DE3752131D1 (de) Impfstoffe und diagnosetest für haemophilus influenzae
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
DE3877136D1 (de) Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung.
NO178504C (no) Fr.måte for fr.stilling av minaktivin,DNA-molekyl,gen,vert,prober,preparat som omfatter prober,reagens for lokalisering og defini. av grenser for tumor i histologiske pröver,samt anvendelse av DNA-molekyl,minaktivin og preparat
JPS6485094A (en) Novel physiologically active polypeptide

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: NORDISK GENTOFTE

Owner name: CHIRON CORPORATION

MA Patent expired